Kolexia
Schick Ulrike Oncologie radiothérapie
Schick Ulrike
Oncologie radiothérapie
Hôpital Morvan
Brest, France
277 Activités
188 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs du poumon Tumeurs de la tête et du cou Tumeurs du col de l'utérus Récidive tumorale locale Carcinomes Carcinome épidermoïde Métastase tumorale Carcinome épidermoïde de la tête et du cou

Collaborateurs

Voir plus
Pradier Olivier
Pradier Olivier
Hôpital Morvan, Brest, France
Lucia Francois
Lucia Francois
Hôpital Morvan, Brest, France
Bourbonne Vincent
Bourbonne Vincent
Hôpital Morvan, Brest, France
Dissaux Gurvan
Dissaux Gurvan
Hôpital Cavale Blanche, Brest, France

Industries

Voir plus
Ipsen
11 collaboration(s)
Dernière en 2023
Janssen
9 collaboration(s)
Dernière en 2022
MSD
4 collaboration(s)
Dernière en 2023
Bayer
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
REPAIR: Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin
Essai Clinique (Institut Cancerologie de l'Ouest)   11 mars 2024
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION): A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Essai Clinique (Emd Serono)   05 mars 2024
The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases.
The British journal of radiology   20 février 2024
PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   15 février 2024
BLAD-RAD01: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   01 février 2024
Inter-Rater Variability of Prostate Lesion Segmentation on Multiparametric Prostate MRI.
Biomedicines   14 décembre 2023
Multicentric development and evaluation of FFDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
European journal of nuclear medicine and molecular imaging   21 novembre 2023
Prediction of acute radiation-induced lung toxicity after SBRT using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CT.
International journal of radiation oncology, biology, physics   22 octobre 2023
PET-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy
ASTRO 2023: 65th Annual Meeting   01 octobre 2023
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
European urology oncology   26 août 2023